{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:00:35Z","timestamp":1740139235066,"version":"3.37.3"},"reference-count":18,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":572,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["1K23HL105784-01A1"],"award-info":[{"award-number":["1K23HL105784-01A1"]}]}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Clin Pract"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1111\/ijcp.12331","type":"journal-article","created":{"date-parts":[[2014,2,6]],"date-time":"2014-02-06T06:48:24Z","timestamp":1391669304000},"page":"568-577","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Does treatment response to ambrisentan vary by pulmonary arterial hypertension severity? Implications for clinicians and for the design of future clinical trials"],"prefix":"10.1155","volume":"68","author":[{"given":"K. M.","family":"Chin","sequence":"first","affiliation":[{"name":"UT Southwestern; Dallas TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bartolome","sequence":"additional","affiliation":[{"name":"UT Southwestern; Dallas TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Miller","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc; Foster City CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Blair","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc; Foster City CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Gillies","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc; Foster City CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Torres","sequence":"additional","affiliation":[{"name":"UT Southwestern; Dallas TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,2,6]]},"reference":[{"issue":"5","key":"10.1111\/ijcp.12331-BIB0001|ijcp12331-cit-0001","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"issue":"9288","key":"10.1111\/ijcp.12331-BIB0002|ijcp12331-cit-0002","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"issue":"12","key":"10.1111\/ijcp.12331-BIB0003|ijcp12331-cit-0003","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1111\/ijcp.12331-BIB0004|ijcp12331-cit-0004","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1111\/ijcp.12331-BIB0005|ijcp12331-cit-0005","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2010.01.027","article-title":"Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial","volume":"55","author":"McLaughlin","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1111\/ijcp.12331-BIB0006|ijcp12331-cit-0006","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.healun.2010.11.009","article-title":"Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension","volume":"30","author":"Barst","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"20","key":"10.1111\/ijcp.12331-BIB0007|ijcp12331-cit-0007","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1111\/ijcp.12331-BIB0008|ijcp12331-cit-0008","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 1","key":"10.1111\/ijcp.12331-BIB0009|ijcp12331-cit-0009","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1097\/01.fjc.0000166207.74178.d0","article-title":"STRIDE 1: effects of the selective ET(A) receptor antagonist, sitaxsentan sodium, in a patient population with pulmonary arterial hypertension that meets traditional inclusion criteria of previous pulmonary arterial hypertension trials","volume":"44","author":"Langleben","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"issue":"23","key":"10.1111\/ijcp.12331-BIB0010|ijcp12331-cit-0010","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2","volume":"117","author":"Galie","year":"2008","journal-title":"Circulation"},{"issue":"21","key":"10.1111\/ijcp.12331-BIB0011|ijcp12331-cit-0011","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.jacc.2009.07.033","article-title":"Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension","volume":"54","author":"Oudiz","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1111\/ijcp.12331-BIB0012|ijcp12331-cit-0012","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)","volume":"30","author":"Galie","year":"2009","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1111\/ijcp.12331-BIB0013|ijcp12331-cit-0013","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","article-title":"ACCF\/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1111\/ijcp.12331-BIB0014|ijcp12331-cit-0014","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1111\/ijcp.12331-BIB0015|ijcp12331-cit-0015","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1183\/09031936.00072709","article-title":"Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation","volume":"35","author":"Thenappan","year":"2010","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1111\/ijcp.12331-BIB0016|ijcp12331-cit-0016","doi-asserted-by":"crossref","first-page":"521","DOI":"10.7326\/0003-4819-149-8-200810210-00004","article-title":"Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial","volume":"149","author":"Simonneau","year":"2008","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1111\/ijcp.12331-BIB0017|ijcp12331-cit-0017","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.amjcard.2011.06.021","article-title":"Meta-analysis of monotherapy versus combination therapy for pulmonary arterial hypertension","volume":"108","author":"Fox","year":"2011","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1111\/ijcp.12331-BIB0018|ijcp12331-cit-0018","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","article-title":"Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival","volume":"40","author":"Sitbon","year":"2002","journal-title":"J Am Coll Cardiol"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.12331","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:08:10Z","timestamp":1643350090000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.12331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,6]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"URL":"https:\/\/doi.org\/10.1111\/ijcp.12331","relation":{},"ISSN":["1368-5031"],"issn-type":[{"type":"print","value":"1368-5031"}],"subject":[],"published":{"date-parts":[[2014,2,6]]},"assertion":[{"value":"2014-02-06","name":"published_online","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}